Abiopharma

News list

(70% Positive) ENVVENO MEDICAL CORP (NVNO) Announces Enrollment Update for care Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment

Full text

News bot April 29, 2026, 12:26 p.m.
📋 ENVVENO MEDICAL CORP (NVNO) - Clinical Trial Update

Filing Date: 2026-04-29

Accepted: 2026-04-29 08:25:22

Event Type: Clinical Trial Update
Event Details:
ENVVENO MEDICAL CORP (NVNO) Announces Clinical Trial Update ENVVENO MEDICAL CORP (NVNO) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: care, evaluated
Diseases/Conditions: approximately 3 million U, TAVVE U
Clinical Stage: Pivotal Study, Pivotal Trial
Collaboration: IDE
Updated Timeline: Q3 2027
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: ENVVENO MEDICAL CORP
- Ticker Symbol: NVNO